AIM: To perform a systematic review of incidental or unsuspected gallbladder (GB) cancer diagnosed during or after cholecystectomy. METHODS: Data in PubMed, EMBASE, and Cochrane Library were reviewed and 26 publications were included in the meta-analysis. The inclusion criterion for incidental GB cancer was GB cancer diagnosed during or after cholecystectomy that was not suspected at a preoperative stage. Pooled proportions of the incidence, distribution of T stage, and revisional surgery of incidental GB cancer were analyzed. RESULTS: The final pooled population comprised 2145 patients with incidental GB cancers. Incidental GB cancers were found in 0.7% of cholecystectomies performed for benign gallbladder diseases on preoperative diagnosis (95%CI: 0.004-0.012). Nearly 50% of the incidental GB cancers were stage T2 with a pooled proportion of 47.0% (95%CI: 0.421-0.519). T1 and T3 GB cancers were found at a similar frequency, with pooled proportions of 23.0% (95%CI: 0.178-0.291) and 25.1% (95%CI: 0.195-0.317), respectively. The pooled proportion that completed revisional surgery for curative intent was 40.9% (95%CI: 0.329-0.494). The proportion of patients with unresectable disease upon revisional surgery was 23.0% (95%CI: 0.177-0.294). CONCLUSION: A large proportion of incidental GB cancers were T2 and T3 lesions. Revisional surgery for radical cholecystectomy is warranted in T2 and more advanced cancers.
AIM: To perform a systematic review of incidental or unsuspected gallbladder (GB) cancer diagnosed during or after cholecystectomy. METHODS: Data in PubMed, EMBASE, and Cochrane Library were reviewed and 26 publications were included in the meta-analysis. The inclusion criterion for incidental GB cancer was GB cancer diagnosed during or after cholecystectomy that was not suspected at a preoperative stage. Pooled proportions of the incidence, distribution of T stage, and revisional surgery of incidental GB cancer were analyzed. RESULTS: The final pooled population comprised 2145 patients with incidental GB cancers. Incidental GB cancers were found in 0.7% of cholecystectomies performed for benign gallbladder diseases on preoperative diagnosis (95%CI: 0.004-0.012). Nearly 50% of the incidental GB cancers were stage T2 with a pooled proportion of 47.0% (95%CI: 0.421-0.519). T1 and T3 GB cancers were found at a similar frequency, with pooled proportions of 23.0% (95%CI: 0.178-0.291) and 25.1% (95%CI: 0.195-0.317), respectively. The pooled proportion that completed revisional surgery for curative intent was 40.9% (95%CI: 0.329-0.494). The proportion of patients with unresectable disease upon revisional surgery was 23.0% (95%CI: 0.177-0.294). CONCLUSION: A large proportion of incidental GB cancers were T2 and T3 lesions. Revisional surgery for radical cholecystectomy is warranted in T2 and more advanced cancers.
Entities:
Keywords:
Cholecystectomy; Gallbladder cancer; Incidental diagnosis; Laparoscopic surgery; Revisional surgery
Authors: Ajay V Maker; Jean M Butte; Jacqueline Oxenberg; Deborah Kuk; Mithat Gonen; Yuman Fong; Ronald P Dematteo; Michael I D'Angelica; Peter J Allen; William R Jarnagin Journal: Ann Surg Oncol Date: 2011-06-23 Impact factor: 5.344
Authors: Gennaro Clemente; Gennaro Nuzzo; Agostino Maria De Rose; Ivo Giovannini; Giuseppe La Torre; Francesco Ardito; Felice Giuliante Journal: J Gastrointest Surg Date: 2012-06-01 Impact factor: 3.452
Authors: Cecilia G Ethun; Nina Le; Alexandra G Lopez-Aguiar; Timothy M Pawlik; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley A Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Maria C Russell; Shishir K Maithel Journal: Am Surg Date: 2017-07-01 Impact factor: 0.688
Authors: Cecilia G Ethun; Lauren M Postlewait; Nina Le; Timothy M Pawlik; Stefan Buettner; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Nipun Merchant; Kenneth Cardona; Shishir K Maithel Journal: Ann Surg Oncol Date: 2016-11-03 Impact factor: 5.344
Authors: Cecilia G Ethun; Lauren M Postlewait; Nina Le; Timothy M Pawlik; Stefan Buettner; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; David A Kooby; Shishir K Maithel Journal: JAMA Surg Date: 2017-02-01 Impact factor: 14.766
Authors: Cecilia G Ethun; Lauren M Postlewait; Nina Le; Timothy M Pawlik; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley A Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Kenneth Cardona; Shishir K Maithel Journal: J Surg Oncol Date: 2017-02-23 Impact factor: 3.454
Authors: Ramazan Kozan; Safa Özaydın; Hüseyin Bayhan; Sezai Leventoğlu; Ahmet Karamercan; Ahmet Ziya Anadol; Mustafa Şare; Abdülkadir Bülent Aytaç Journal: Turk J Gastroenterol Date: 2021-02 Impact factor: 1.852
Authors: Linda Lundgren; Carolina Muszynska; Axel Ros; Gunnar Persson; Oliver Gimm; Lars Valter; Bodil Andersson; Per Sandström Journal: World J Surg Date: 2018-04 Impact factor: 3.352